(Q35174125)

6 August 2017

1 reference

title

Viruses as potential targets for therapy in HIV-associated malignancies (English)

1 reference

6 August 2017

Richard F Ambinder

1

1 reference

6 August 2017

publication date

1 June 2003

1 reference

Hematology / Oncology Clinics of North America

6 August 2017

published in

1 reference

6 August 2017

volume

17

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

697-702, v-vi

1 reference

Molecular virology of Kaposi's sarcoma-associated herpesvirus

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900045-5

7 January 2021

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900045-5

7 January 2021

Epstein-Barr virus: exploiting the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900045-5

7 January 2021

Identification of Epstein-Barr virus strain variants in hairy leukoplakia and peripheral blood by use of a heteroduplex tracking assay

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900045-5

7 January 2021

Diagnosis and treatment of posttransplantation lymphoproliferative disease after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900045-5

7 January 2021

IATROGENIC KAPOSI???S SARCOMA HHV8 Positivity Persists But The Tumors Regress Almost Completely Without Immunosuppressive Therapy 1

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900045-5

7 January 2021

Generation of autologous Epstein-Barr virus-specific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900045-5

7 January 2021

Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900045-5

7 January 2021

Definition of an optimal cytotoxic T lymphocyte epitope in the latently expressed Kaposi's sarcoma-associated herpesvirus kaposin protein

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900045-5

7 January 2021

Impaired CTL recognition of cells latently infected with Kaposi's sarcoma-associated herpes virus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900045-5

7 January 2021

The ubiquitin/proteasome system in Epstein-Barr virus latency and associated malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900045-5

7 January 2021

A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900045-5

7 January 2021

Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900045-5

7 January 2021

Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus--positive Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900045-5

7 January 2021

Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900045-5

7 January 2021

Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900045-5

7 January 2021

Role of Epstein-Barr virus in Burkitt's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900045-5

7 January 2021

10.1016/S0889-8588(03)00045-5

Identifiers

DOI

1 reference

6 August 2017

1 reference